Rx Policy Title | Policy Number | Effective Date |
---|
AbobotulinumtoxinA (Dysport) (PDF) | CP.PHAR.230 | 05/16/2019 |
ACEI ARB Duplicate Therapy (PDF) | CP.PMN.61 | 05/17/2019 |
Acitretin (Soriatane) (PDF) | CP.PMN.40 | 05/06/2020 |
adamts13, recombinant krhn (Adzynma) (PDF) | CP.PHAR.635 | 05/01/2024 |
Ado-Trastuzumab Emtansine (Kadcyla) (PDF) | CP.PHAR.229 | 08/13/2019 |
Aducanumab (Aduhelm) (PDF) | CP.PHAR.468 | 07/01/2021 |
afamelanotide (Scenesse) (PDF) | CP.PHAR.444 | 01/01/2025 |
Afamitresgene Autoleucel (Tecelra) (PDF) | CP.PHAR.678 | 10/01/2024 |
aflibercept (Eylea) (PDF) | CP.PHAR.184 | 02/13/2019 |
agalsidase beta (Fabrazyme) (PDF) | CP.PHAR.158 | 05/16/2019 |
Alemtuzumab (Lemtrada) (PDF) | CP.PHAR.243 | 05/14/2019 |
alglucosidase alfa (Lumizyme) (PDF) | CP.PHAR.160 | 05/16/2019 |
Allogeneic cultured keratinocytes and dermal fibroblasts (StrataGraft) (PDF) | CP.PHAR.562 | 03/01/2022 |
Allogenic processed thymus tissue-agdc (Rethymic) (PDF) | CP.PHAR.563 | 03/01/2022 |
Alpha-1 Proteinase Inhibitors (Aralast NP, Glassia, Prolastin-C, Zemaira) (PDF) | CP.PHAR.94 | 06/26/2019 |
Amifampridine (Firdapse) (PDF) | CP.PHAR.411 | 09/13/2019 |
Amisulpride (Barhemsys) (PDF) | CP.PMN.236 | 05/06/2020 |
Amivantamab-vmjw (Rybrevant) (PDF) | CP.PHAR.544 | 09/01/2021 |
anifrolumab-fnia (Saphnelo) (PDF) | CP.PHAR.551 | 12/01/2021 |
Antithrombin III (ATryn, Thrombate III) (PDF) | CP.PHAR.564 | 03/01/2022 |
Antithymocyte Globulin (Atgam, Thymoglobulin) (PDF) | CP.PHAR.506 | 11/01/2020 |
Aprocitentan (Tryvio) (PDF) | CP.PHAR.676 | 06/01/2024 |
Arimoclomol (Miplyffa) (PDF) | CP.PHAR.510 | 01/01/2025 |
asenapine (Saphris) (PDF) | CP.PMN.15 | 02/15/2019 |
asfotase alfa (Strensiq) (PDF) | CP.PHAR.328 | 11/20/2018 |
atezolizumab (Tecentriq) (PDF) | CP.PHAR.235 | 05/20/2019 |
Atidarsagene Autotemcel (Lenmeldy) (PDF) | CP.PHAR.602 | 08/01/2024 |
Avacincaptad pegol (Izervay) (PDF) | CP.PHAR.641 | 10/01/2023 |
Avalglucosidase Alfa (NeoGAA) (PDF) | CP.PHAR.521 | 06/01/2021 |
avelumab (Bacencio) (PDF) | CP.PHAR.333 | 06/26/2019 |
Axatilimab-csfr (Niktimvo) (PDF) | CP.PHAR.691 | 10/01/2024 |
axicabtagene ciloleucel (Yescarta) (PDF) | CP.PHAR.362 | 08/16/2019 |
azacitidine (Onureg, Vidaza) (PDF) | CP.PHAR.387 | 11/20/2018 |
Baclofen (Gablofen, Lioresal, Lyvispah, Ozobax) (PDF) | CP.PHAR.149 | 11/14/2018 |
Bedaquiline (Sirturo) (PDF) | CP.PMN.212 | 05/06/2020 |
Belantamab mafodotin (Blenrep) (PDF) | CP.PHAR.469 | 06/01/2021 |
belatacept (Nulojix) (PDF) | CP.PHAR.201 | 11/14/2018 |
belimumab (Benlysta) (PDF) | CP.PHAR.88 | 08/10/2019 |
belinostat (Beleodaq) (PDF) | CP.PHAR.311 | 11/17/2018 |
bendamustine (Bendeka, Treanda) (PDF) | CP.PHAR.307 | 11/14/2018 |
Benznidazole (PDF) | CP.PMN.90 | 02/18/2019 |
Berdazimer (Zelsuvmi) (PDF) | CP.PMN.293 | 04/01/2024 |
Beremagene Geperpavec (Vyjuvek) (PDF) | CP.PHAR.592 | 03/01/2023 |
betaine (Cystadane) (PDF) | CP.PHAR.143 | 11/20/2018 |
Betibeglogene Autotemcel (Zynteglo) (PDF) | CP.PHAR.545 | 12/01/2022 |
bevacizumab (Avastin, Mvasi) (PDF) | CP.PHAR.93 | 06/26/2019 |
Bexarotene (Targretin) (PDF) | CP.PHAR.75 | 05/16/2019 |
bezlotoxumab (Zinplava) (PDF) | CP.PHAR.300 | 02/15/2019 |
Bimatoprost (Durysta) (PDF) | CP.PHAR.486 | 11/01/2020 |
Bimekizumab-bkzx (Bimzelx) (PDF) | CP.PHAR.660 | 02/01/2024 |
Birch triterpenes (Filsuvez) (PDF) | CP.PHAR.669 | 02/01/2024 |
blinatumomab (Blincyto) (PDF) | CP.PHAR.312 | 08/13/2019 |
Bortezomib (Velcade) (PDF) | CP.PHAR.410 | 02/19/2019 |
Brand Name Override (PDF) | CP.PMN.22 | 02/19/2019 |
Bremelanotide (Vyleesi) (PDF) | CP.PHAR.434 | 05/06/2020 |
brentuximab Vedotin (Adcetris) (PDF) | CP.PHAR.303 | 08/13/2019 |
Brexanolone (Zulresso) (PDF) | CP.PHAR.417 | 05/13/2019 |
Brexpiprazole (Rexulti) (PDF) | CP.PMN.68 | 05/06/2020 |
Brexucabtagene Autoleucel (Tecartus) (PDF) | CP.PHAR.472 | 09/01/2020 |
Brimonidine (Mirvaso) (PDF) | CP.PMN.192 | 05/13/2019 |
brivaracetam (Briviact) (PDF) | CP.PMN.297 | 01/01/2025 |
Brolucizumab (Beovu) (PDF) | CP.PHAR.445 | 04/01/2021 |
buprenorphine implant (Sublocade) (PDF) | CP.PHAR.289 | 06/01/2023 |
Burosumab-twza (Crysvita) (PDF) | CP.PHAR.11 | 08/10/2019 |
cabazitaxel (Jevtana) (PDF) | CP.PHAR.316 | 09/13/2019 |
Cabotegravir, Cabotegravir-Rilpivirine (Apretude, Cabenuva) (PDF) | CP.PHAR.573 | 06/01/2022 |
calcifediol (Rayaldee) (PDF) | CP.PMN.76 | 08/16/2019 |
canakinumab (Ilaris) (PDF) | CP.PHAR.246 | 05/16/2019 |
Cannabidiol (Epidiolex) (PDF) | CP.PMN.164 | 08/17/2019 |
Caplacizumab-yhdp (Cablivi) (PDF) | CP.PHAR.416 | 05/13/2019 |
Carbamazepine ER (Equetro) (PDF) | CP.PMN.137 | 05/17/2019 |
carfilzomib (Kyprolis) (PDF) | CP.PHAR.309 | 11/14/2018 |
carglumic acid (Carbaglu) (PDF) | CP.PHAR.206 | 02/14/2019 |
Cariprazine (Vraylar) (PDF) | CP.PMN.91 | 06/26/2019 |
Casimersen (Amondys) (PDF) | CP.PHAR.470 | 06/01/2021 |
Cemiplimab-rwlc (Libtayo) (PDF) | CP.PHAR.397 | 11/26/2018 |
Cenegermin-bkbj (Oxervate (PDF) | CP.PMN.186 | 08/14/2019 |
Cenobamate (Xcopri) (PDF) | CP.PMN.231 | 11/01/2020 |
Cerliponase alfa (Brineura) (PDF) | CP.PHAR.338 | 08/15/2019 |
cetuximab (Erbitux) (PDF) | CP.PHAR.317 | 11/17/2018 |
Chloramphenicol (PDF) | CP.PHAR.388 | 02/15/2019 |
Chronic Use of Opioid Analgesics (PDF) | NE.PMN.97 | 12/06/2018 |
Ciltacabtagene Autoleucel (Carvykti) (PDF) | CP.PHAR.533 | 05/01/2021 |
cinacalcet (Sensipar) (PDF) | CP.PHAR.61 | 08/10/2019 |
Cipaglucosidase alfa-miglustat (Pombiliti) PDF) | CP.PHAR.567 | 11/01/2023 |
clobazam (Onfi) (PDF) | CP.PMN.54 | 06/26/2019 |
collagenase clostridium histolyticum (Xiaflex) (PDF) | CP.PHAR.82 | 08/15/2019 |
Compounded Medications (PDF) | CP.PMN.280 | 08/01/2022 |
Conjugated estrogens-bazedoxifene (Duavee) (PDF) | CP.PMN.258 | 03/01/2021 |
Continuous Glucose Monitors (PDF) | NE.PMN.214 | 09/2024 |
copanlisib (Aliqopa) (PDF) | CP.PHAR.357 | 11/20/2018 |
Corticosteroid Intravitreal Implants (Iluvien, Ozurdex, Retisert) (PDF) | CP.PHAR.385 | 09/13/2019 |
cosyntropin (Cortrosyn) (PDF) | CP.PHAR.203 | 02/13/2019 |
Crizanlizumab-tmca (Adakveo) (PDF) | CP.PHAR.449 | 06/01/2021 |
Crovalimab-akkz (Piasky) (PDF) | CP.PHAR.664 | 09/01/2024 |
cysteamine (Cystagon, Procysbi) (PDF) | CP.PHAR.155 | 05/16/2019 |
Cysteamine ophthalmic (Cystaran) (PDF) | CP.PMN.130 | 05/17/2019 |
Cytomegalovirus Immune Globulin (CytoGam) (PDF) | CP.PHAR.277 | 08/15/2019 |
Danicopan (Voydeya) (PDF) | CP.PHAR.665 | 07/01/2024 |
daptomycin (Cubicin, Cubicin RF) (PDF) | CP.PHAR.351 | 08/15/2019 |
daratumumab (Darzalex) (PDF) | CP.PHAR.310 | 08/13/2019 |
daunorubicin/cytarabine (Vyxeos) (PDF) | CP.PHAR.352 | 11/20/2018 |
DaxibotulinumtoxinA-lanm (Daxxify) (PDF) | CP.PHAR.651 | 10/01/2023 |
deferasirox (Jadenu) (PDF) | CP.PHAR.145 | 08/10/2019 |
deferiprone (Ferriprox) (PDF) | CP.PHAR.147 | 08/17/2019 |
deferoxamine (Desferal) (PDF) | CP.PHAR.146 | 08/15/2019 |
deflazacort (Emflaza) (PDF) | CP.PHAR.331 | 07/01/2024 |
degarelix acetate (Firmagon) (PDF) | CP.PHAR.170 | 11/17/2018 |
Delandistrogene Moxeparvovec (Elevidys) (PDF) | CP.PHAR.593 | 09/01/2023 |
Denileukin Diftitox-cxdl (Lymphir) (PDF) | CP.PHAR.693 | 10/01/2024 |
Denosumab (Prolia, Xgeva), Denosumab-bbdz (Jubbonti, Wyost) (PDF) | CP.PHAR.58 | 05/16/2019 |
Desmopressin acetate (DDAVP Injection, Stimate, Noctiva) (PDF) | CP.PHAR.214 | 02/13/2019 |
Dexrazoxane (Zinecard Totect) (PDF) | CP.PHAR.418 | 05/13/2019 |
Dextromethorphan/Bupropion (Auvelity) (PDF) | CP.PMN.284 | 01/01/2023 |
Dextromethorphan-Quinidine (Nuedexta) (PDF) | CP.PMN.93 | 02/18/2019 |
Diazepam (Libervant, Valtoco) (PDF) | CP.PMN.216 | 12/01/2019 |
Dichlorphenamide (Keveyis) (PDF) | CP.PMN.261 | 03/01/2021 |
Donanemab (Kinsunla) (PDF) | CP.PHAR.594 | 09/01/2024 |
Dostarlimab-gxly (Jemperli) (PDF) | CP.PHAR.540 | 07/01/2021 |
dornase alfa (Pulmozyme) (PDF) | CP.PHAR.212 | 07/01/2024 |
droxidopa (Northera) (PDF) | CP.PMN.17 | 11/13/2018 |
Duplicate SSRI/SNRI Therapy (PDF) | CP.PMN.60 | 08/15/2019 |
Durvalumab (Imfinzi) (PDF) | CP.PHAR.339 | 07/19/2019 |
Early and Periodic Screening, Diagnostic, and Treatment Benefit for Pediatric Members (PDF) | CP.PMN.234 | 10/01/2022 |
ecallantide (Kalbitor) (PDF) | CP.PHAR.177 | 09/01/2021 |
eculizumab (Soliris) (PDF) | CP.PHAR.97 | 05/14/2019 |
Edaravone (Radicava) (PDF) | CP.PHAR.343 | 05/16/2019 |
Efgartigimod (Vyvgart, Vyvgart Hytrulo) (PDF) | CP.PHAR.555 | 03/01/2022 |
Eladocagene Exuparvovec (Kebilidi) (PDF) | CP.PHAR.595 | 01/01/2025 |
Elapegademase-lvlr (Revcovi) (PDF) | CP.PHAR.419 | 05/13/2019 |
Elivaldogene autotemcel (Skysona) (PDF) | CP.PHAR.556 | 12/01/2022 |
elosulfase alfa (Vimizim) (PDF) | CP.PHAR.162 | 05/16/2019 |
elotuzumab (Empliciti) (PDF) | CP.PHAR.308 | 05/14/2019 |
Elranatamab-bcmm (Elrexfio) (PDF) | CP.PHAR.652 | 10/01/2023 |
Emapalumab-lzsg (Gamifant) (PDF) | CP.PHAR.402 | 05/30/2019 |
Enfortumab Vedotin-ejfv (Padcev) (PDF) | CP.PHAR.455 | 09/01/2021 |
Epcoritamab-bysp (Epkinly) (PDF) | CP.PHAR.634 | 11/01/2023 |
Eplontersen (Wainua) (PDF) | CP.PHAR.633 | 02/01/2024 |
epoprostenol (Flolan), Veletri) (PDF) | CP.PHAR.192 | 04/02/2019 |
Eptinezumab (Vyepti) (PDF) | CP.PHAR.489 | 05/06/2020 |
eribulin Mesylate (Halaven) (PDF) | CP.PHAR.318 | 11/17/2018 |
erwina asparaginase (Erwinaze) (PDF) | CP.PHAR.301 | 02/15/2019 |
Esketamine (Spravato) (PDF) | CP.PMN.199 | 09/13/2019 |
Estradiol Vaginal Ring (Femring) (PDF) | CP.PMN.263 | 01/01/2022 |
etelcalcetide (Parsabiv) (PDF) | CP.PHAR.379 | 08/13/2019 |
eteplirsen (Exondys 51) (PDF) | CP.PHAR.288 | 02/15/2019 |
Etranacogene Dezaparvovec (Hemgenix) (PDF) | CP.PHAR.580 | 03/01/2023 |
Evinacumab (Evkeeza) (PDF) | CP.PHAR.511 | 06/01/2021 |
Exagamglogene Autotemcel (Casgevy) (PDF) | CP.PHAR.603 | 02/01/2024 |